Literature DB >> 6802474

Effects of various inhibitory agents on sporulation of Bacillus subtilis.

I Takahashi, L W MacKenzie.   

Abstract

Electron microscopic examinations of Bacillus subtilis cells revealed that relatively high concentrations of carbon sources blocked sporulation at stage 0 in most cells. Both nalidixic acid and novobiocin blocked sporulation at stage 0. The cells treated with acridine orange showed the morphology of stage IV 5 h after the end of exponential growth, but no further progression was observed. Mutants that are able to sporulate in the presence of these agents had the characteristic morphological changes observed in uninhibited cultures.

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6802474     DOI： 10.1139/m82-006

Source DB:  PubMed          Journal:  Can J Microbiol        ISSN： 0008-4166            Impact factor:   2.419


  5 in total

1.  Differential regulation of spo0A transcription in Bacillus subtilis: glucose represses promoter switching at the initiation of sporulation.

Authors:  T Chibazakura; F Kawamura; H Takahashi
Journal:  J Bacteriol       Date:  1991-04       Impact factor: 3.490

Review 2.  Bacterial spores and chemical sporicidal agents.

Authors:  A D Russell
Journal:  Clin Microbiol Rev       Date:  1990-04       Impact factor: 26.132

3.  Genetic mapping of rpoD implicates the major sigma factor of Bacillus subtilis RNA polymerase in sporulation initiation.

Authors:  C W Price; R H Doi
Journal:  Mol Gen Genet       Date:  1985

4.  Glucose-resistant sporulation in Bacillus subtilis crsA47 mutants does not depend on promoter switching at the spo0A gene.

Authors:  Laurie G Dixon; George B Spiegelman
Journal:  J Bacteriol       Date:  2002-03       Impact factor: 3.490

5.  Catabolite-resistant sporulation (crsA) mutations in the Bacillus subtilis RNA polymerase sigma 43 gene (rpoD) can suppress and be suppressed by mutations in spo0 genes.

Authors:  F Kawamura; L F Wang; R H Doi
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.